MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas

BACKGROUND: Currently, no reliable predictive clinical or laboratory tests exist that can accurately distinguish between benign and malignant pheochromocytomas or paragangliomas (PPGLs). The aim of this study was to investigate if serum microRNA-210 (miR-210) levels could be a marker of malignancy i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Surg Res
Main Authors: Ruff, Samantha M., Ayabe, Reed I., Malekzadeh, Parisa, Good, Meghan L., Wach, Michael M., Gonzales, Melissa K., Tirosh, Amit, Nilubol, Naris, Pacak, Karel, Kebebew, Electron, Patel, Dhaval
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7478339/
https://ncbi.nlm.nih.gov/pubmed/31146085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2019.04.086
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados